The cut-off value for the HALP score wascalculated using the X-tile software program.Results: HALP score was found to be high (≥16.98) in 26 patients and low (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: In the treatment of metastatic RCC, nivolumab has been used with increasing frequency in recent years.Systemic inflammation plays an important role in the initiation and progression of cancer.
📊
Key Findings & Data:In this study, we aimed toinvestigate whether the HALP score, which indicates systemic inflammation, has a predictive significance in patientsreceiving nivolumab treatment for mRCC.Methods: 45 patients who were treated with nivolumab after first-line anti-angiogenic therapy for mRCC in our clinicand whose files were analyzed retrospectively were included in the study.
💡
Conclusion & Impact:The cut-off value for the HALP score wascalculated using the X-tile software program.Results: HALP score was found to be high (≥16.98) in 26 patients and low (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objectives: In the treatment of metastatic RCC, nivolumab has been used with increasing frequency in recent years.Systemic inflammation plays an important role in the initiation and progression of cancer. In this study, we aimed toinvestigate whether the HALP score, which indicates systemic inflammation, has a predictive significance in patientsreceiving nivolumab treatment for mRCC.Methods: 45 patients who were treated with nivolumab after first-line anti-angiogenic therapy for mRCC in our clinicand whose files were analyzed retrospectively were included in the study. The cut-off value for the HALP score wascalculated using the X-tile software program.Results: HALP score was found to be high (≥16.98) in 26 patients and low (
🔖
Cite This Article
YILMAZ, M. (2022). Is There Predictive Significance of HALP Score in Metastatic RCC Patients Treated with Nivolumab?. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 1, 33–38. https://ajindex.com/articles/508606
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, et al; National comprehensive cancer network. Kidney cancer, version 3.2015. J Natl Compr Canc Netw 2015;13:151–9
Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015;373:1803–13
McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009;12:223–6
Jiang H, Li H, Li A, Tang E, Xu D, Chen Y, et al. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget 2016;7:72076–83
Peng D, Zhang CJ, Gong YQ, Hao H, Guan B, Li XS, et al. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Sci Rep 2018;8:794
Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004;10:7252–9
Efremova M, Rieder D, Klepsch V, Charoentong P, Finotello F, Hackl H, et al. Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nat Commun 2018;9:32
Xia L, Hu G, Guzzo TJ. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis. Anticancer Res 2017;37:3175–81
Ko K, Park YH, Lee JW, Ku JH, Kwak C, Kim HH. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC). BJU Int 2013;112:775–80
Huszno J, Kolosza Z, Mrochem Kwarciak J, Rutkowsi T, Skladowksi K. The role of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and platelets in the prognosis of metastatic renal cell carcinoma. Oncology 2019;97:7–17
Gatenby R, Gillies R. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891–9
Zhang J, Yao YH, Li BG, Yang Q, Zhang PY, Wang HT. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and metaanalysis. Sci Rep 2015;5:9800
Shen J, Chen Z, Zhuang Q, Fan M, Ding T, Lu H, et al. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0166482
Peng D, Zhang CJ, Tang Q, Zhang L, Yang KW, Yu XT, et al. Prognostic significance of the combination of preope